Advertising

Mylan CEO defends EpiPen strategy, questions pricing model in the U.S.

Mylan CEO defends EpiPen strategy, questions pricing model in the U.S.

By

Heather Bresch's appearance at industry summit came after she declined to attend a congressional hearing scheduled for the same day.

Five things for pharma marketers to know: Monday, November 28, 2016

Five things for pharma marketers to know: Monday, November 28, 2016

By

J&J in talks to buy Actelion; Novo Nordisk pulls ads on Breitbart News; Takeda to market Ninlaro in Europe

Pharma Marketers Using Programmatic, Consider Privacy and Measurement

Pharma Marketers Using Programmatic, Consider Privacy and Measurement

There's a reason pharma lags on the programmatic adoption curve: It's a heavily regulated industry, and there are concerns around privacy.

PulsePoint launches health vertical for programmatic advertising

PulsePoint launches health vertical for programmatic advertising

By

The programmatic advertising technology company also hired Chris Neuner as SVP and GM of digital health.

Centron's Letty Albarran talks ads that get personal

Centron's Letty Albarran talks ads that get personal

Here are six campaigns that connect with the patient on a personal level.

10 things for pharma marketers to know about Facebook and Instagram

10 things for pharma marketers to know about Facebook and Instagram

By

With about 70 million users in six million health-related groups, drugmakers have tremendous opportunity to reach key audiences on Facebook. Here's how.

Drugmakers, facing pricing criticism, sell cures in new ads

Drugmakers, facing pricing criticism, sell cures in new ads

By

With lawmakers, patients, and physicians crying foul over pricing, drugmakers are trying to shift the narrative — with mixed results. Can a new focus on storytelling help?

Sermo and Everyday Health partner in advertising-research deal

Sermo and Everyday Health partner in advertising-research deal

By

The partnership allows Sermo to expand the reach of its research initiatives and Everyday Health to scale its targeted advertising on the social platform.

Best Professional Print Campaign of 2016

Best Professional Print Campaign of 2016

By

With a product approved for both major depressive disorder and schizophrenia, the companies decided to create a campaign that provided cohesion and brand recognition across disease states.

Best TV Advertising Campaign of 2016

Best TV Advertising Campaign of 2016

By

In just six weeks, more than 50% of blood thinner Pradaxa's target audience had become aware of the Redfish campaign.

Merck's creative archive tells an industry story

Merck's creative archive tells an industry story

By

Did you know that Norman Rockwell was a medical illustrator for Merck?

30 years later, DTC's complicated past still hasn't deterred marketers

30 years later, DTC's complicated past still hasn't deterred marketers

By

Given its modern-day ubiquity, it's easy to forget that pharma DTC didn't exist until the 1980s rolled around.

Why the FDA's view of patient communication evolved over time

Why the FDA's view of patient communication evolved over time

By

The agency's ambitions were fueled in part by external criticism. The barbs that stung most sharply were ones suggesting a certain indifference on the FDA's part.

How to get more women in the C-suite, according to IPG, Unilever, and AOL

How to get more women in the C-suite, according to IPG, Unilever, and AOL

By

A new report analyzing gender parity in advertising found that men tend to endorse other men at higher rates than women. Execs share their insights about the issue.

Five things for pharma marketers to know: Friday, September 23, 2016

Five things for pharma marketers to know: Friday, September 23, 2016

By

Anthem and Cigna accuse each other of violating merger terms; Alzheimer's experimental drug fails late-stage study; study calls for new approach to eradicate global epidemics

Ogilvy's Michael Johnston on Using the Familiar in Diabetes Ads

Ogilvy's Michael Johnston on Using the Familiar in Diabetes Ads

The science behind new diabetes drugs underscores how far we've come from the days of purified pork insulin. Even so, most ads stick to traditional copy.

Five things for pharma marketers to know: Wednesday, September 14, 2016

Five things for pharma marketers to know: Wednesday, September 14, 2016

By

Patients who ask for a prescription after seeing an ad are more likely to get one; Mylan's executive pay is now under scrutiny

Sex, chocolate, and disability: What marketers can learn from Mars' Maltesers campaign

Sex, chocolate, and disability: What marketers can learn from Mars' Maltesers campaign

By

The latest TV campaign from Mars features a woman with cerebral palsy joking about her love life.

MM&M's top 5 stories in August 2016

MM&M's top 5 stories in August 2016

By

Shire hires Jennifer Aniston for a disease awareness campaign; critics argue that the direct-to-consumer ads for Opdivo are misleading, while Merck's Keytruda takes the lead in first-line cancer

Mylan's branded ad spending on the EpiPen rose 357% — to $43 million in 2015 — over five years

Mylan's branded ad spending on the EpiPen rose 357% — to $43 million in 2015 — over five years

By

In 2011 the drugmaker spent $9.4 million on branded ads for the EpiPen. By 2015, branded ad spending hit $43 million.

Verywell and Cleveland Clinic to partner on health content site

Verywell and Cleveland Clinic to partner on health content site

By

The companies said they are also exploring opportunities to allow Cleveland Clinic experts to contribute to Verywell in the future.

DDB brings delegates face to face with realities of addiction

DDB brings delegates face to face with realities of addiction

By

By focusing on accomplished people, the campaign is meant to show that addiction isn't a moral failing, but a physical condition that requires medical help.

The Story Behind the Story, Live From Cannes, Presented by McCann Health

The Story Behind the Story, Live From Cannes, Presented by McCann Health

McCann Health, the 2016 Lions Health Network of the Year, and Campaign invited top marketers and visionary artists to discuss creativity during this year's Lions Health festival.

DigitasLBi's Carlos Ricque on Why Simple Ads Are the Hardest to Make

DigitasLBi's Carlos Ricque on Why Simple Ads Are the Hardest to Make

The key to a successful ad? Think simple with an unexpected twist.

GSK Consumer Healthcare to prioritize digital after agency review

GSK Consumer Healthcare to prioritize digital after agency review

By

Now that it has consolidated its global agency roster, GSK Consumer Healthcare aims to increase digital marketing efforts.

Novartis ups marketing investment in Entresto, by $200 million

Novartis ups marketing investment in Entresto, by $200 million

By

One oft-cited challenge to Entresto's adoption has been prior authorization requirements.

Arnold's Gary Scheiner to lead creative at ghg

Arnold's Gary Scheiner to lead creative at ghg

By

Scheiner has held jobs in and out of healthcare over the course of his career.

Asia-Pacific to overtake North America in ad spending

Asia-Pacific to overtake North America in ad spending

By

Globally, digital ad spend this year is expected to grow by 12.6% to $176.7 billion, accounting for 32% of all ad spend.

The Future of Data-Driven Marketing is Now

The Future of Data-Driven Marketing is Now

Healthcare marketing is evolving more rapidly than ever before — and not surprisingly, the demand for smarter media campaign measurement is increasing as a result.

Five things for pharma marketers to know: Tuesday, July 12, 2016

Five things for pharma marketers to know: Tuesday, July 12, 2016

By

U.S. cancer centers triple spending on advertising; study finds patient choice can reduce side effects; the FDA approves Shire's dry-eye drug

OPINION

Email Newsletters